MetaADEDB 2.0 @ LMMD
Procarbazine
(DERJYEZSLHIUKF-UHFFFAOYSA-N)
Structure
SMILES
CNNCc1ccc(cc1)C(=O)NC(C)C.Cl
Molecular Formula:
C12H20ClN3O
Molecular Weight:
257.760
Log P:
3.0235
Hydrogen Bond Acceptor:
4
Hydrogen Bond Donor:
4
TPSA:
53.16
CAS Number(s):
366-70-1
Synonym(s)
1.
Procarbazine
2.
Matulane
3.
Natulan
4.
Procarbazine Hydrochloride
5.
Procarbazine Monohydrobromide
6.
Procarbazine Monohydrochloride
7.
Hydrochloride, Procarbazine
8.
Monohydrobromide, Procarbazine
9.
Monohydrochloride, Procarbazine
External Link(s)
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1NauseaFAERS: 146US FAERS
2FatigueFAERS: 100US FAERS
3Disease ProgressionFAERS: 54US FAERS
4Blood count abnormalFAERS: 46US FAERS
5VomitingFAERS: 43US FAERS
6ConstipationFAERS: 40US FAERS
7White blood cell count decreasedFAERS: 33US FAERS
8Drug ineffectiveFAERS: 21US FAERS
9UrticariaFAERS: 21US FAERS
10DizzinessFAERS: 18US FAERS
11HeadacheFAERS: 18US FAERS
12PneumoniaFAERS: 15US FAERS
13AstheniaFAERS: 14US FAERS
14DehydrationFAERS: 14US FAERS
15NeutropeniaFAERS: 13US FAERS
16Nonspecific reactionFAERS: 13US FAERS
17MalaiseFAERS: 12US FAERS
18Malignant neoplasm progressionFAERS: 12US FAERS
19PainFAERS: 12US FAERS
20Abdominal PainFAERS: 10US FAERS
21Febrile NeutropeniaFAERS: 8US FAERS
22InfectionFAERS: 8US FAERS
23Cerebrovascular accidentFAERS: 7US FAERS
24MyalgiaFAERS: 7US FAERS
25StomatitisFAERS: 7US FAERS
26Weight decreasedFAERS: 7US FAERS
27HypersensitivityFAERS: 6US FAERS
28Adverse eventFAERS: 5US FAERS
29AlopeciaFAERS: 5US FAERS
30ArthralgiaFAERS: 5US FAERS
31PancytopeniaFAERS: 5US FAERS
32Peripheral swellingFAERS: 5US FAERS
33SepsisFAERS: 5US FAERS
34HypotensionFAERS: 4US FAERS
35InfluenzaFAERS: 4US FAERS
36LymphomaFAERS: 4US FAERS
37PruritusFAERS: 4US FAERS
38Pulmonary EmbolismFAERS: 4US FAERS
39ThrombosisFAERS: 4US FAERS
40TremorFAERS: 4US FAERS
41Abdominal discomfortFAERS: 3US FAERS
42Bone painFAERS: 3US FAERS
43Intestinal ObstructionFAERS: 3US FAERS
44LethargyFAERS: 3US FAERS
45LeukopeniaFAERS: 3US FAERS
46SyncopeFAERS: 3US FAERS
47ThrombocytopeniaFAERS: 3US FAERS
48AgitationFAERS: 2US FAERS
49Back PainFAERS: 2US FAERS
50Blood creatinine increasedFAERS: 2US FAERS
51Blood glucose increasedFAERS: 2US FAERS
52Blood potassium decreasedFAERS: 2US FAERS
53Blood sodium decreasedFAERS: 2US FAERS
54Burning sensationFAERS: 2US FAERS
55Chest PainFAERS: 2US FAERS
56ChillsFAERS: 2US FAERS
57Clostridium difficile colitisFAERS: 2US FAERS
58Clostridium difficile infectionFAERS: 2US FAERS
59Deep Vein ThrombosisFAERS: 2US FAERS
60Device related infectionFAERS: 2US FAERS
61Drug dose omissionFAERS: 2US FAERS
62DysgeusiaFAERS: 2US FAERS
63DyspepsiaFAERS: 2US FAERS
64Full blood count decreasedFAERS: 2US FAERS
65HyperthyroidismFAERS: 2US FAERS
66Memory impairmentFAERS: 2US FAERS
67NasopharyngitisFAERS: 2US FAERS
68Nerve injuryFAERS: 2US FAERS
69Neurological infectionFAERS: 2US FAERS
70Pain of skinFAERS: 2US FAERS
71Respiratory FailureFAERS: 2US FAERS
72Septic ShockFAERS: 2US FAERS
73Unevaluable eventFAERS: 2US FAERS
74Visual ImpairmentFAERS: 2US FAERS
75AbasiaFAERS: 1US FAERS
76AcneFAERS: 1US FAERS
77Allergy to arthropod biteFAERS: 1US FAERS
78Ammonia increasedFAERS: 1US FAERS
79AmnesiaFAERS: 1US FAERS
80AngerFAERS: 1US FAERS
81Angina PectorisFAERS: 1US FAERS
82AnxietyFAERS: 1US FAERS
83Atrial FibrillationFAERS: 1US FAERS
84Blood count normalFAERS: 1US FAERS
85Cardiac ArrestFAERS: 1US FAERS
86CardiotoxicityFAERS: 1US FAERS
87CholecystitisFAERS: 1US FAERS
88ColitisFAERS: 1US FAERS
89Completed SuicideFAERS: 1US FAERS
90Diffuse Large B-Cell LymphomaFAERS: 1US FAERS
91DisorientationFAERS: 1US FAERS
92Dry skinFAERS: 1US FAERS
93EpistaxisFAERS: 1US FAERS
94EructationFAERS: 1US FAERS
95ErythemaFAERS: 1US FAERS
96Escherichia infectionFAERS: 1US FAERS
97Failure to ThriveFAERS: 1US FAERS
98Feeling ColdFAERS: 1US FAERS
99Gait inabilityFAERS: 1US FAERS
100GlioblastomaFAERS: 1US FAERS
101GliomaFAERS: 1US FAERS
102Heart alternationFAERS: 1US FAERS
103Heat ExhaustionFAERS: 1US FAERS
104Hospice CareFAERS: 1US FAERS
105HyperchlorhydriaFAERS: 1US FAERS
106HypoxiaFAERS: 1US FAERS
107ImmunosuppressionFAERS: 1US FAERS
108Joint swellingFAERS: 1US FAERS
109Lobar PneumoniaFAERS: 1US FAERS
110LymphadenopathyFAERS: 1US FAERS
111MYELODYSPLASTIC SYNDROMEFAERS: 1US FAERS
112Medication ErrorFAERS: 1US FAERS
113Mental status changesFAERS: 1US FAERS
114Mood swingsFAERS: 1US FAERS
115Muscle tightnessFAERS: 1US FAERS
116Musculoskeletal stiffnessFAERS: 1US FAERS
117Myocardial InfarctionFAERS: 1US FAERS
118NervousnessFAERS: 1US FAERS
119Neutrophil count decreasedFAERS: 1US FAERS
120Night sweatsFAERS: 1US FAERS
121No adverse eventFAERS: 1US FAERS
122Oral painFAERS: 1US FAERS
123Oropharyngeal painFAERS: 1US FAERS
124PancreatitisFAERS: 1US FAERS
125Pathogen resistanceFAERS: 1US FAERS
126Peripheral arterial occlusive diseaseFAERS: 1US FAERS
127Peripheral paralysisFAERS: 1US FAERS
128PneumonitisFAERS: 1US FAERS
129RhinitisFAERS: 1US FAERS
130Skin UlcerFAERS: 1US FAERS
131Skin irritationFAERS: 1US FAERS
132TachycardiaFAERS: 1US FAERS
133Thermal burnFAERS: 1US FAERS
134Throat irritationFAERS: 1US FAERS
135ToothacheFAERS: 1US FAERS
136Toxicity to various agentsFAERS: 1US FAERS
137UlcerFAERS: 1US FAERS
138Unresponsive to stimuliFAERS: 1US FAERS
139Urinary RetentionFAERS: 1US FAERS
140Urinary tract infectionFAERS: 1US FAERS
141White blood cell count abnormalFAERS: 1US FAERS
142effusionFAERS: 1US FAERS
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120239

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.